These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4004976)

  • 21. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
    Whitcup SM; Salvo EC; Nussenblatt RB
    Am J Ophthalmol; 1994 Jul; 118(1):39-45. PubMed ID: 8023874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical-immunological disorders in uveitis in patients with Behçet's syndrome].
    Teplinskaia LE; Kaliberdina AF; Zaĭtseva NS; Bulanova TD; Katsnel'son LA
    Vestn Oftalmol; 1994; 110(3):23-5. PubMed ID: 7810037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cyclosporin A in the treatment of uveitis in Behçet's disease: apropos of a case].
    Annonier P; Brini A
    Bull Soc Ophtalmol Fr; 1986 Mar; 86(3):305-8. PubMed ID: 3802341
    [No Abstract]   [Full Text] [Related]  

  • 24. Behçet's disease and streptococcal infection.
    Namba K; Ueno T; Okita M
    Jpn J Ophthalmol; 1986; 30(4):385-401. PubMed ID: 3586405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behçet's disease].
    Stokvis JC
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1585-6. PubMed ID: 3670445
    [No Abstract]   [Full Text] [Related]  

  • 27. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
    Kurata I; Tsuboi H; Takahashi H; Abe S; Ebe H; Hagiwara S; Umeda N; Kondo Y; Ogishima H; Suzuki T; Matsumoto I; Hoshi S; Oshika T; Sumida T
    Intern Med; 2015; 54(12):1553-7. PubMed ID: 26073249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cyclosporin A (CsA) treatment on gingival tissue of patients with Behçet's disease.
    Pisanty S; Shoshan S; Chajek T; Maftsir G; Sacks B; BenEzra D
    J Periodontol; 1988 Sep; 59(9):599-603. PubMed ID: 3183921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].
    Wang Y; Yang L; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):910-914. PubMed ID: 27752180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
    Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
    Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.
    Yamamoto JH; Minami M; Inaba G; Masuda K; Mochizuki M
    Br J Ophthalmol; 1993 Sep; 77(9):584-9. PubMed ID: 8218058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A: alterations of the cellular immune response in S-antigen-induced experimental autoimmune uveitis.
    Nussenblatt RB; Salinas-Carmona M; Waksman BH; Gery I
    Int Arch Allergy Appl Immunol; 1983; 70(4):289-94. PubMed ID: 6600715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
    Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
    Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin A.
    Page EH; Wexler DM; Guenther LC
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):785-91. PubMed ID: 3519696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
    Levinsky RJ; Lehner T
    Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.
    Pacor ML; Biasi D; Lunardi C; Cortina P; Caramaschi P; Girelli D; Botto M; Urbani G; Lombardo G; Bambara LM
    Clin Rheumatol; 1994 Jun; 13(2):224-7. PubMed ID: 8088063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.